roivant news - Search News

Roivant, Organon

Barron's on MSN · 6d

Roivant Flips a Skin Drug to Organon

Selling plaque psoriasis drug Vtama to Organon looks like another win for Roivant, which has been buying overlooked drugs, and then selling them for big returns.

GlobalData on MSN · 5d

Organon makes $1.2bn play for Roivant’s immuno-dermatology subsidiary

As part of the acquisition, Organon will acquire psoriasis treatment Vtama, which could soon be approved in atopic dermatitis.

Organon to buy Roivant's dermatology unit for up to $1.2 billion

Shares of Roivant, which owns 86% of Dermavant as of March 31, 2024, and was founded by former Republican presidential candidate Vivek Ramaswamy, were up 1.7% at $12.26 in early trading. However, Organon was down 1.4%. Dermavant's Vtama cream, approved by ...

BioPharma Dive · 6d

Roivant dermatology subsidiary to be acquired by Organon

The deal hands Organon a psoriasis and eczema cream called Vtama, while Roivant will get more cash to fund its R&D plans.

6h

Is Roivant Sciences Ltd. (ROIV) the Best Guru Stock To Buy Now?

Due to the plethora of investment options such as equities, bonds, and mutual funds that are available today, picking the ...

Pharmalittle: We’re reading about a Roivant deal, limited access to medicines and more

Top of the morning to you and a fine one it is. Blue skies, cool breezes and plenty of chirping birds are enveloping the ...

Organon pays up to $1.2B to acquire Dermavant and its steroid-free skin cream Vtama

Organon is set to acquire Roivant’s immuno-dermatology subsidiary Dermavant for up to $1.2 billion, the companies announced ...

ENDPOINTS NEWS6d

Roivant makes another deal, selling Dermavant to Organon for up to $1.2B

Roivant is once again reaping the benefits of its bespoke business model. This time, it's selling Dermavant to Organon for up ...

15d

What's Going In With Vivek Ramaswamy-Founded Roivant Sciences Stock On Monday?

Immunovant reports promising Phase 2a trial results for batoclimab in treating Graves' Disease, showing a high response rate ...

6d

Roivant Sciences Offloads Psoriasis Medicine Maker To Organon For Up To $1.2B

Organon & Co (NYSE:OGN) has agreed to acquire Roivant Sciences Ltd’s (NASDAQ:ROIV) Dermavant Sciences Ltd, which is focused ...

Bernie Sanders keeps the heat on Novo’s high prices

Sen. Bernie Sanders has been probing the high prices that Novo charges for Ozempic and Wegovy. Yesterday, he share that ...

pharmaphorum14d

Roivant's new 'vant' emerges to advance Bayer lung drug

Roivant's latest biotech company launch – Pulmovant – has made its debut with a plan to develop a respiratory drug licensed ...

5d

Roivant's Sale Of Dermavant To Organon: A Strategic Win-Win In Atopic Dermatitis

Organon acquires ROIV's Dermavant for $1.2B, expanding their dermatology portfolio and potentially increasing sales. Click ...

Results that may be inaccessible to you are currently showing.

Hide inaccessible results